Logo image of 1MSTR.MI

MICROSTRATEGY INC-CL A (1MSTR.MI) Stock Fundamental Analysis

BIT:1MSTR - Euronext Milan - US5949724083 - Common Stock - Currency: EUR

320.7  -6.5 (-1.99%)

Fundamental Rating

2

Overall 1MSTR gets a fundamental rating of 2 out of 10. We evaluated 1MSTR against 102 industry peers in the Software industry. 1MSTR may be in some trouble as it scores bad on both profitability and health. 1MSTR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

1MSTR had positive earnings in the past year.
In the past year 1MSTR has reported a negative cash flow from operations.
1MSTR had negative earnings in 4 of the past 5 years.
1MSTR had a positive operating cash flow in 4 of the past 5 years.
1MSTR.MI Yearly Net Income VS EBIT VS OCF VS FCF1MSTR.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5B -10B -15B -20B

1.2 Ratios

1MSTR has a worse Return On Assets (-12.16%) than 75.49% of its industry peers.
The Return On Equity of 1MSTR (-15.93%) is worse than 69.61% of its industry peers.
Industry RankSector Rank
ROA -12.16%
ROE -15.93%
ROIC N/A
ROA(3y)-18.83%
ROA(5y)-14.41%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1MSTR.MI Yearly ROA, ROE, ROIC1MSTR.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300

1.3 Margins

1MSTR has a Gross Margin of 70.95%. This is comparable to the rest of the industry: 1MSTR outperforms 51.96% of its industry peers.
1MSTR's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for 1MSTR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 70.95%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.22%
GM growth 5Y-1.93%
1MSTR.MI Yearly Profit, Operating, Gross Margins1MSTR.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

More info and screens

3

2. Health

2.1 Basic Checks

1MSTR does not have a ROIC to compare to the WACC, probably because it is not profitable.
1MSTR has more shares outstanding than it did 1 year ago.
1MSTR has more shares outstanding than it did 5 years ago.
The debt/assets ratio for 1MSTR has been reduced compared to a year ago.
1MSTR.MI Yearly Shares Outstanding1MSTR.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
1MSTR.MI Yearly Total Debt VS Total Assets1MSTR.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

An Altman-Z score of 6.01 indicates that 1MSTR is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 6.01, 1MSTR is doing good in the industry, outperforming 71.57% of the companies in the same industry.
1MSTR has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
1MSTR has a Debt to Equity ratio (0.24) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Altman-Z 6.01
ROIC/WACCN/A
WACC8.6%
1MSTR.MI Yearly LT Debt VS Equity VS FCF1MSTR.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B -20B

2.3 Liquidity

1MSTR has a Current Ratio of 0.66. This is a bad value and indicates that 1MSTR is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.66, 1MSTR is doing worse than 82.35% of the companies in the same industry.
1MSTR has a Quick Ratio of 0.66. This is a bad value and indicates that 1MSTR is not financially healthy enough and could expect problems in meeting its short term obligations.
1MSTR's Quick ratio of 0.66 is on the low side compared to the rest of the industry. 1MSTR is outperformed by 82.35% of its industry peers.
Industry RankSector Rank
Current Ratio 0.66
Quick Ratio 0.66
1MSTR.MI Yearly Current Assets VS Current Liabilites1MSTR.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

3

3. Growth

3.1 Past

1MSTR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 202.05%, which is quite impressive.
The Revenue has decreased by -6.19% in the past year.
Measured over the past years, 1MSTR shows a decrease in Revenue. The Revenue has been decreasing by -0.96% on average per year.
EPS 1Y (TTM)202.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%891.77%
Revenue 1Y (TTM)-6.19%
Revenue growth 3Y-3.19%
Revenue growth 5Y-0.96%
Sales Q2Q%-3.63%

3.2 Future

The Earnings Per Share is expected to grow by 60.44% on average over the next years. This is a very strong growth
Based on estimates for the next years, 1MSTR will show a decrease in Revenue. The Revenue will decrease by -0.79% on average per year.
EPS Next Y93.19%
EPS Next 2Y39.28%
EPS Next 3Y60.44%
EPS Next 5YN/A
Revenue Next Year-1.13%
Revenue Next 2Y1.11%
Revenue Next 3Y2.63%
Revenue Next 5Y-0.79%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
1MSTR.MI Yearly Revenue VS Estimates1MSTR.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
1MSTR.MI Yearly EPS VS Estimates1MSTR.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 5 -5 10 -10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 391.10, 1MSTR can be considered very expensive at the moment.
1MSTR's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 26.34, 1MSTR is valued quite expensively.
The Forward Price/Earnings Ratio is negative for 1MSTR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 391.1
Fwd PE N/A
1MSTR.MI Price Earnings VS Forward Price Earnings1MSTR.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 200 -200 -400 -600 -800

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
1MSTR.MI Per share data1MSTR.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 100

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as 1MSTR's earnings are expected to grow with 60.44% in the coming years.
PEG (NY)4.2
PEG (5Y)N/A
EPS Next 2Y39.28%
EPS Next 3Y60.44%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for 1MSTR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MICROSTRATEGY INC-CL A

BIT:1MSTR (6/19/2025, 7:00:00 PM)

320.7

-6.5 (-1.99%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-05 2025-05-05/amc
Earnings (Next)07-30 2025-07-30/amc
Inst Owners50.01%
Inst Owner ChangeN/A
Ins Owners0.18%
Ins Owner ChangeN/A
Market Cap87.68B
Analysts81.11
Price Target430.88 (34.36%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)857.58%
Min EPS beat(2)-4213.73%
Max EPS beat(2)5928.88%
EPS beat(4)1
Avg EPS beat(4)52.49%
Min EPS beat(4)-4213.73%
Max EPS beat(4)5928.88%
EPS beat(8)3
Avg EPS beat(8)-279.81%
EPS beat(12)4
Avg EPS beat(12)-9128.41%
EPS beat(16)7
Avg EPS beat(16)-6875.11%
Revenue beat(2)0
Avg Revenue beat(2)-5%
Min Revenue beat(2)-6%
Max Revenue beat(2)-3.99%
Revenue beat(4)0
Avg Revenue beat(4)-7.02%
Min Revenue beat(4)-10.88%
Max Revenue beat(4)-3.99%
Revenue beat(8)1
Avg Revenue beat(8)-6.04%
Revenue beat(12)2
Avg Revenue beat(12)-4.59%
Revenue beat(16)3
Avg Revenue beat(16)-3.98%
PT rev (1m)8.05%
PT rev (3m)2.71%
EPS NQ rev (1m)23.54%
EPS NQ rev (3m)27.57%
EPS NY rev (1m)0%
EPS NY rev (3m)3.75%
Revenue NQ rev (1m)-0.33%
Revenue NQ rev (3m)-2.46%
Revenue NY rev (1m)-1.2%
Revenue NY rev (3m)-2.43%
Valuation
Industry RankSector Rank
PE 391.1
Fwd PE N/A
P/S 219.12
P/FCF N/A
P/OCF N/A
P/B 3
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0.82
EY0.26%
EPS(NY)-0.34
Fwd EYN/A
FCF(TTM)-89.81
FCFYN/A
OCF(TTM)-0.27
OCFYN/A
SpS1.46
BVpS106.83
TBVpS-31.93
PEG (NY)4.2
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.16%
ROE -15.93%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 70.95%
FCFM N/A
ROA(3y)-18.83%
ROA(5y)-14.41%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.22%
GM growth 5Y-1.93%
F-Score2
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 87678.7%
Cap/Sales 6118.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.66
Quick Ratio 0.66
Altman-Z 6.01
F-Score2
WACC8.6%
ROIC/WACCN/A
Cap/Depr(3y)33259.4%
Cap/Depr(5y)26278.5%
Cap/Sales(3y)1735.12%
Cap/Sales(5y)1190.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)202.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%891.77%
EPS Next Y93.19%
EPS Next 2Y39.28%
EPS Next 3Y60.44%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.19%
Revenue growth 3Y-3.19%
Revenue growth 5Y-0.96%
Sales Q2Q%-3.63%
Revenue Next Year-1.13%
Revenue Next 2Y1.11%
Revenue Next 3Y2.63%
Revenue Next 5Y-0.79%
EBIT growth 1Y-573.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year102.35%
EBIT Next 3Y81.44%
EBIT Next 5YN/A
FCF growth 1Y-10861.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2632.86%
OCF growth 3YN/A
OCF growth 5YN/A